Consultation of Table 2 indicates that the best vesicular targets with the highest discriminating power between PCa and BPH is the combination of STAT3, CyclinD1, and CD81, which achieves the best performance in terms of the overall classification of positive and negative samples, as specified by the highest accuracy. This evidence concerns the gene CD81 and benign prostatic hyperplasia.